CIK 0001226616 · Non-accelerated filer<br>Smaller reporting company
MEDICINOVA INC
Sign in to watch- Ticker
- MNOV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330927979
- Phone
- 858-373-1500
- Business address
- 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,728,000
- in 1 filing
Net −$1,728,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-09 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +157,500 | 157,500 | ||
| 2024-01-09 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2023-08-04 | Lemerond Nicole Director | Grant or award · Stock Option (Right to Buy) | +18,333 | 18,333 | ||
| 2023-06-13 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-06-13 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-01-23 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +235,125 | 235,125 | ||
| 2023-01-23 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +76,950 | 76,950 | ||
| 2023-01-23 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +149,625 | 149,625 | ||
| 2022-11-28 | Nagao Hideki Director | Sale | −6,754 | $2.25 | $15K | 0 |
| 2022-11-22 | Nagao Hideki Director | Sale | −218 | $2.13 | $464 | 6,754 |
| 2022-11-21 | Nagao Hideki Director | Sale | −5,365 | $2.18 | $12K | 6,972 |
| 2022-11-17 | Nagao Hideki Director | Sale | −309 | $2.18 | $674 | 12,337 |
| 2022-06-16 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-06-16 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-01-27 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +99,000 | 99,000 | ||
| 2022-01-27 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +192,500 | 192,500 | ||
| 2022-01-27 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +302,500 | 302,500 | ||
| 2021-08-23 | Matsuda Kazuko Chief Medical Officer | Option exercise | +60,000 | $2.30 | $138K | 322,996 |
| 2021-08-23 | Matsuda Kazuko Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2021-07-09 | IWAKI YUICHI President and CEO | Option exercise | +39,583 | $2.54 | $101K | 966,933 |
Page 2 of 8 · 149 trades